These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 16230228

  • 1. Ezrin expression in prostate cancer and benign prostatic tissue.
    Valdman A, Fang X, Pang ST, Nilsson B, Ekman P, Egevad L.
    Eur Urol; 2005 Nov; 48(5):852-7. PubMed ID: 16230228
    [Abstract] [Full Text] [Related]

  • 2. Expression of ezrin in prostatic intraepithelial neoplasia.
    Pang ST, Fang X, Valdman A, Norstedt G, Pousette A, Egevad L, Ekman P.
    Urology; 2004 Mar; 63(3):609-12. PubMed ID: 15028477
    [Abstract] [Full Text] [Related]

  • 3. Heat shock proteins 27, 60 and 70 as prognostic markers of prostate cancer.
    Glaessgen A, Jonmarker S, Lindberg A, Nilsson B, Lewensohn R, Ekman P, Valdman A, Egevad L.
    APMIS; 2008 Oct; 116(10):888-95. PubMed ID: 19132982
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Zinc-alpha2-glycoprotein expression as a predictor of metastatic prostate cancer following radical prostatectomy.
    Henshall SM, Horvath LG, Quinn DI, Eggleton SA, Grygiel JJ, Stricker PD, Biankin AV, Kench JG, Sutherland RL.
    J Natl Cancer Inst; 2006 Oct 04; 98(19):1420-4. PubMed ID: 17018789
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Reverse transcriptase-polymerase chain reaction and immunohistochemical studies for detection of prostate stem cell antigen expression in prostate cancer: potential value in molecular staging of prostate cancer.
    Joung JY, Yang SO, Jeong IG, Han KS, Seo HK, Chung J, Park WS, Lee KH.
    Int J Urol; 2007 Jul 04; 14(7):635-43. PubMed ID: 17645609
    [Abstract] [Full Text] [Related]

  • 13. Predictive value of prostate-specific antigen expression in prostate cancer: a tissue microarray study.
    Erbersdobler A, Isbarn H, Steiner I, Schlomm T, Chun F, Mirlacher M, Sauter G.
    Urology; 2009 Nov 04; 74(5):1169-73. PubMed ID: 19476978
    [Abstract] [Full Text] [Related]

  • 14. Radical prostatectomy for incidental (stage T1a-T1b) prostate cancer: analysis of predictors for residual disease and biochemical recurrence.
    Capitanio U, Scattoni V, Freschi M, Briganti A, Salonia A, Gallina A, Colombo R, Karakiewicz PI, Rigatti P, Montorsi F.
    Eur Urol; 2008 Jul 04; 54(1):118-25. PubMed ID: 18314255
    [Abstract] [Full Text] [Related]

  • 15. Expression of Ki-67, cyclin D1 and apoptosis markers correlated with survival in prostate cancer patients treated by radical prostatectomy.
    Aaltomaa S, Kärjä V, Lipponen P, Isotalo T, Kankkunen JP, Talja M, Mokka R.
    Anticancer Res; 2006 Jul 04; 26(6C):4873-8. PubMed ID: 17214354
    [Abstract] [Full Text] [Related]

  • 16. Decreased immunostaining for macrophage scavenger receptor is associated with poor prognosis of prostate cancer.
    Takayama H, Nonomura N, Nishimura K, Oka D, Shiba M, Nakai Y, Nakayama M, Tsujimura A, Aozasa K, Okuyama A.
    BJU Int; 2009 Feb 04; 103(4):470-4. PubMed ID: 18778349
    [Abstract] [Full Text] [Related]

  • 17. Immunohistochemical expression of tumor antigens MAGE-A1, MAGE-A3/4, and NY-ESO-1 in cancerous and benign prostatic tissue.
    Hudolin T, Juretic A, Spagnoli GC, Pasini J, Bandic D, Heberer M, Kosicek M, Cacic M.
    Prostate; 2006 Jan 01; 66(1):13-8. PubMed ID: 16114059
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A comparison of p21 and p27 immunoexpression in benign glands, prostatic intraepithelial neoplasia and prostate adenocarcinoma.
    Doganavsargil B, Simsir A, Boyacioglu H, Cal C, Hekimgil M.
    BJU Int; 2006 Mar 01; 97(3):644-8. PubMed ID: 16469041
    [Abstract] [Full Text] [Related]

  • 20. Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma.
    Chuang AY, DeMarzo AM, Veltri RW, Sharma RB, Bieberich CJ, Epstein JI.
    Am J Surg Pathol; 2007 Aug 01; 31(8):1246-55. PubMed ID: 17667550
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.